Increased oxidative stress and altered substrate metabolism in obese children

Stacy R Oliver1, Jaime S Rosa, Ginger L Milne

  • 1Department of Pharmacology, School of Medicine, University of California, Irvine, CA 92697, USA. soliver@uci.edu

Insights

Pediatric obesity is linked to increased inflammation and oxidative stress, raising cardiovascular disease risk in children. These metabolic changes occur early, affecting both genders similarly.

Area of Science:

  • Pediatric endocrinology
  • Cardiovascular health
  • Metabolic disorders

Background:

  • Pediatric obesity prevalence has risen significantly.
  • Obesity is a known risk factor for cardiovascular diseases and diabetes in adults.
  • The biochemical links between childhood obesity, inflammation, and oxidative stress are not well understood.

Purpose of the Study:

  • To investigate systemic markers of oxidation and inflammation in peripubertal children.
  • To examine the relationship between dyslipidemia, oxidative stress, and inflammation in obese children.
  • To assess the influence of gender and fitness on these metabolic and inflammatory markers.

Main Methods:

  • Measured systemic oxidation markers (F(2)-isoprostanes, antioxidants) and inflammation markers (interleukin-6, leukocyte counts).
  • Assessed metabolic variables including lipids, glucose, and insulin.
  • Studied 113 peripubertal children: 55 obese, 15 overweight, and 43 normal weight.

Main Results:

  • Obese children showed elevated F(2)-isoprostanes and IL-6 compared to normal-weight children.
  • Increased total leukocytes and neutrophils were observed in obese children.
  • Obese children exhibited altered levels of cholesterol, triglycerides, free fatty acids, glucose, and insulin, irrespective of gender or fitness level.

Conclusions:

  • Metabolic control alterations and increased inflammation/oxidative stress are present early in obese children.
  • These early changes may increase cardiovascular disease risk in both genders.
  • Findings highlight the need for early intervention in pediatric obesity.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.